3.69 USD
↘ 0.08 (2.12%)AT CLOSE (03:59 PM EST)
Bicycle Therapeutics plc American Depositary Shares
BCYCNASDAQ • USD
3.69
↘ 0.01 (0.14%)
POST MARKET (AS OF 04:15 PM EST)
Post Market
AS OF 04:15 PM EST
3.69
↘ 0.01 (0.14%)
Market: CLOSED
BCYC is currently priced at $3.68. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest BCYC is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 10, 2026.
Open?$3.77
High?$3.78
Low?$3.65
Prev. Close?$3.77
Volume?234.7K
Avg. Volume?462.6K
VWAP?$3.70
Rel. Volume?0.51x
Bid / Ask
Bid?$2.99 × 100
Ask?$4.39 × 100
Spread?$1.40
Midpoint?$3.69
Valuation & Ratios
Market Cap?264.3M
Shares Out?50.7M
P/E Ratio?N/A
P/B Ratio?0.52
EPS?-$2.02
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
Employees
288
Market Cap
264.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-05-23
Address
BLOCKS A & B, PORTWAY BUILDING
CAMBRIDGE, X0 CB21 6GS
Phone: 011441223261503
CAMBRIDGE, X0 CB21 6GS
Phone: 011441223261503
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?4
Momentum?65
Short Sent.?29
Piotroski F-Score?4/9Mixed
Altman Z-Score?0.31Distress
Confidence?59%Low
Short InterestHigh
Short Interest?3.9M
Days to Cover?8.4
Avg Daily Volume460.3K
Settlement Date2026-10-30
Financial Health
Current Ratio?12.09Strong
Quick Ratio?12.09Strong
Cash Ratio?10.57Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?0.52CHEAP▾
Peers100
S&P97
P/S?3.16FAIR▾
Peers100
S&P48
P/FCF?N/A▾
EV/EBITDA?1.3CHEAP▾
Peers100
S&P97
EV/Sales?-2.46CHEAP▾
S&P97
Returns & Efficiency
ROE?-28.1%WEAK▾
S&P6
ROA?-25.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-177036000
Enterprise Value?$-205674521
Fundamentals ratios updated end of day